高阮玲, 羅喻才, 馬詠儀, 王國凱, 周忠玉,3*
木麻黃根乙酸乙酯部位化學(xué)成分研究
高阮玲1,2, 羅喻才2,3, 馬詠儀2,3, 王國凱1*, 周忠玉1,2,3*
(1. 安徽中醫(yī)藥大學(xué)藥學(xué)院中藥研究與開發(fā)安徽省重點(diǎn)實(shí)驗(yàn)室,合肥 230012;2. 中國科學(xué)院華南農(nóng)業(yè)植物分子分析與遺傳改良重點(diǎn)實(shí)驗(yàn)室, 廣東省應(yīng)用植物學(xué)重點(diǎn)實(shí)驗(yàn)室, 中國科學(xué)院華南植物園,廣州 510650;3. 華南國家植物園,廣州 510650)
為闡明木麻黃()的化學(xué)成分,采用有機(jī)溶劑提取、萃取及多種分離技術(shù),從其根中分離得到14個(gè)化合物。經(jīng)光波譜分析,其結(jié)構(gòu)分別鑒定為5-hydroxy-3-methoxyphenyl-6--syringoyl--d-glucopyranoside (1), 高良姜苷A (2), heterophylloside C (3)、6¢--vanilloylisotachioside (4)、3,4,5-trimethoxyphenyl-6--syringoyl--d-glucopyranoside (5)、香草醛(6)、丁香醛(7)、3,4-二羥基苯甲醛(8)、齊墩果酸(9)、樺木酸(10)、胡蘿卜苷(11)、胡蘿卜苷亞油酸酯(12)、(±)-lyoniresinol 2---rhamnoside (13)和(-)-9-acetyl-isolariciresinol 9¢---l-rhamnopyranoside (14),其中化合物14為新的木脂素。
木麻黃;化學(xué)成分;木脂素
木麻黃()為木麻黃科(Casuarinaceae)木麻黃屬植物,原產(chǎn)于澳大利亞及太平洋島嶼,越南、泰國、緬甸、菲律賓、馬來西亞、印度尼西亞、巴布亞新幾內(nèi)亞也有分布,廣東、廣西、福建、臺灣沿海一帶普遍種植[1]。木麻黃具有重要的藥用價(jià)值,樹皮、枝、葉、種子都可入藥[2]。據(jù)《中華本草》記載,木麻黃具有宣肺止咳、行氣止痛,溫中止瀉,利濕的功效[2]?,F(xiàn)代天然藥物化學(xué)對木麻黃植物的研究發(fā)現(xiàn),該植物具有豐富多樣的生物活性,包括抗氧化[3]、抗菌[4]、抗痘[5]、腎保護(hù)[6]、神經(jīng)保護(hù)[7]、鎮(zhèn)痛[8]等多種生物活性。國內(nèi)外關(guān)于木麻黃葉、皮、根瘤、凋落物的次級代謝產(chǎn)物都有研究報(bào)道[9],然而關(guān)于木麻黃根的次級代謝產(chǎn)物相對空白。前期我們從木麻黃根中分離鑒定了4個(gè)新的和6個(gè)已知的大環(huán)二芳基庚烷類化學(xué)成分[10]。本研究繼續(xù)報(bào)道木麻黃根的化學(xué)成分,分離鑒定了1個(gè)新的木脂素,(-)-9-acetyl-isolariciresinol9¢--- l-rhamnopyranoside (14),以及13個(gè)已知化合物。
試驗(yàn)材料由中國林業(yè)科學(xué)院熱帶林業(yè)研究所仲崇祿教授和張勇教授于2020年6月采自于廣東省吳川市。
柱層析硅膠(80~100、200~300目)、薄層硅膠層析板HSGF254 (煙臺江友硅膠開發(fā)公司);葡聚糖凝膠Sephadex LH-20 (瑞典Amersham Biosciences)。
分析用HPLC (日本Shimadzu公司),配備SPD- M20A二極管陣列檢測器、LC-20AT溶劑輸送泵和SIL-20A自動進(jìn)樣器; 色譜柱為安捷倫ZORBAX SB- Aq (5m, 4.6 mm′250 mm)。半制備/制備用HPLC (日本Shimadzu公司),配備CBM-20A系統(tǒng)控制器、SPD-20A紫外-可見光檢測器和LC-6AD溶劑輸送泵, 色譜柱為Cosmosil公司的5C18-MS-Ⅱ (10ID′250 mm)。制備用MPLC為北京創(chuàng)新通恒科技有限公司的LC3000液相色譜儀。
分析純石油醚、二氯甲烷、乙酸乙酯、甲醇等(天津市百世化工有限公司和天津富宇試劑公司);分析純氯仿、丙酮和硫酸(廣州化學(xué)試劑廠);色譜級甲醇和乙腈(天津市康科德科技有限公司);氘代氯仿、甲醇、吡啶、二甲基亞砜(美國劍橋同位素實(shí)驗(yàn)室(CIL)公司);l-鼠李糖標(biāo)準(zhǔn)品(阿達(dá)瑪斯試劑有限公司)。
木麻黃根曬干粉碎(7.26 kg),用90 %乙醇浸提3次,合并提取液,減壓濃縮得提取物浸膏698.36 g。提取物浸膏用水溶解,倒入分液漏斗依次用石油醚、乙酸乙酯、正丁醇分別萃取3次,合并各部分萃取液,減壓濃縮得到石油醚萃取物10.05 g、乙酸乙酯萃取物35.62 g、正丁醇萃取物24.89 g。本研究對木麻黃根乙酸乙酯萃取物進(jìn)行分離與鑒定,其石油醚與正丁醇萃取物暫未研究。
乙酸乙酯萃取物經(jīng)硅膠柱色譜分離,以二氯甲烷-甲醇洗脫劑(100:0~0:100)梯度洗脫,收集流份, 每份1 L,經(jīng)過薄層色譜分析,合并得到15個(gè)組分F1~F15。F2 (2461.4 mg)經(jīng)硅膠柱層析, 以石油醚-乙酸乙酯(250:1~0:100)洗脫,得到亞組分F2-1~F2- 10。F2-10經(jīng)硅膠柱層析, 以石油醚-乙酸乙酯(100:1~0:100)洗脫,得到亞組分F2-10-1~F2-10-8。F2-10-7經(jīng)葡聚糖凝膠柱層析,二氯甲烷/甲醇(1:1)洗脫,得到亞組分F2-10-7-1~F2-10-7-6。F2-10-7-6經(jīng)HPLC純化,以乙腈-水(19:81)為流動相,流速2 mL/min, 得化合物6 (R=27.5 min, 7.8 mg)。F2-10-8經(jīng)HPLC純化,以乙腈-水(13:87)為流動相,流速2 mL/min, 得化合物7 (R=57.6 min, 10 mg)。F3 (815.1 mg)經(jīng)硅膠柱層析, 以石油醚-乙酸乙酯(250:1~0:100)洗脫,得到亞組分F3-1~F3-10。F3-7經(jīng)葡聚糖凝膠柱層析,二氯甲烷/甲醇(1:1)洗脫,得到亞組分F3-7-1~F3-7-4。F3-7-4經(jīng)HPLC純化,以乙腈-水(89:11)為流動相,流速2 mL/min,得化合物10 (R=37.6 min, 2.1 mg)。F3-9經(jīng)葡聚糖凝膠柱層析,二氯甲烷/甲醇(1:1)洗脫,得到亞組分F3-9-1~F3-9-3, F3-9-2經(jīng)HPLC純化,以乙腈-水(89:11)為流動相,流速2 mL/min,得化合物9 (R=42.6 min, 4.1 mg)。F6 (2126.5 mg)經(jīng)硅膠柱層析, 以石油醚-乙酸乙酯(250:1~0:100)洗脫,得到亞組分F6-1~F6-5。F6-1經(jīng)葡聚糖凝膠柱層析, 二氯甲烷/甲醇(1:1)洗脫,得到亞組分F6-1-1~F6-1-4。F6-1-4經(jīng)HPLC純化,以乙腈-水(27:73)為流動相, 流速2 mL/min,R=10.9 min,得流份F6-1-4-1。F6-1-4-1經(jīng)硅膠柱層析, 以二氯甲烷-甲醇(500:1)洗脫,得化合物8 (3.0 mg)。F7 (3517.7 mg)經(jīng)硅膠柱層析, 以石油醚-乙酸乙酯(250:1~0:100)洗脫,得化合物12(301.0 mg)。F8 (7421.4 mg)經(jīng)中壓液相色譜,以甲醇-水(20:80~100:0)洗脫,得到亞組分F8-1~F8-19。F8-4經(jīng)硅膠柱層析,以二氯甲烷-甲醇(150:1~0:100)洗脫,得到亞組分F8-4-1~F8-4-3。F8-4-3經(jīng)葡聚糖凝膠柱層析,二氯甲烷/甲醇(1:1)洗脫,得到亞組分F8-4-3-1~F8-4- 3-2。F8-4-3-1經(jīng)HPLC純化,以甲醇-水(45:55)為流動相,流速2 mL/min, 得化合物13 (R= 0.9 min, 7.5 mg)。F8-5經(jīng)硅膠柱層析,以二氯甲烷-甲醇(100:1~0:100)洗脫,得到亞組分F8-5-1~F8-5-4。F8-5-3經(jīng)葡聚糖凝膠柱層析,二氯甲烷/甲醇(1:1)洗脫,得到亞組分F8-5-3-1~F8-5-3-3。F8-5-3-1經(jīng)HPLC純化,以甲醇-水(35:65)為流動相,流速2 mL/min, 得化合物1 (R= 27.3 min, 12.5 mg)和2 (R=29.8 min, 9.3 mg)。F8-5- 3-3經(jīng)HPLC純化,以甲醇-水(30:70)為流動相,流速2 mL/min,得化合物3 (R=34.6 min, 3.3 mg)和4 (R=38.1 min, 2.6 mg)。F8-8經(jīng)硅膠柱層析,以二氯甲烷-甲醇(100:1~0:100)洗脫,得到亞組分F8-8-1~F8-8-6。F8-8-4經(jīng)葡聚糖凝膠柱層析,二氯甲烷/甲醇(1:1)洗脫,得到亞組分F8-8-4-1~F8-8- 4-4。F8-8-4-1經(jīng)HPLC純化,以甲醇-水(42:58)為流動相,流速2 mL/min,得化合物5 (R=14.5 min, 9.0 mg)。F8-11-4經(jīng)葡聚糖凝膠柱層析,二氯甲烷/甲醇(1:1)洗脫,得到亞組分F8-11-4-1~F8-11-4-3。F8-11-4-2經(jīng)HPLC純化,以甲醇-水(27:73)為流動相, 流速2 mL/min, 得化合物14 (R=46.3 min, 3.5 mg)。F8-17經(jīng)葡聚糖凝膠柱層析,二氯甲烷/甲醇(1:1)洗脫, 得化合物11 (11.1 mg)?;衔?~14的結(jié)構(gòu)見圖1。
(-)-9-acetyl-isolariciresinol 9¢---l-rhamnopy-ranoside (14) 分子式C28H36O11,灰色無定形固體, 易溶于氯仿;[]D20-59.0 (0.2, MeOH); UV (MeOH)max(log) nm 256 (0.53), 283 (1.65); ESI- MS: 571 [M + Na]+;HR-ESI-MS: 549.2326 [M + H]+(計(jì)算值:549.2330);氫譜和碳譜數(shù)據(jù)見表1。
參考Gou等[11]的方法,取2.5 mg化合物14溶于5 mL 2 mol/L的鹽酸中,100 ℃回流4 h,減壓濃縮至干,加入5 mL蒸餾水溶解,用乙酸乙酯萃取3次,每次5 mL。乙酸乙酯部分為化合物14的苷元,苷元溶解于甲醇,測試旋光值[α]D20=-11.0 (0.1, MeOH)。水部分減壓濃縮至干,加入1 mL濃度為1 mg/mL的l-半胱氨酸甲酯鹽酸鹽吡啶溶液,60 ℃反應(yīng)1 h,加入2L鄰甲苯異硫氰酸酯,再反應(yīng)1 h,減壓濃縮至干,加入1 mL甲醇溶液溶解,濾液經(jīng)高效液相分析,以乙腈/水/乙酸(21:79:0.1)為流動相,流速為1 mL/min。l-鼠李糖以同樣方法進(jìn)行衍生化反應(yīng),并使用高效液相分析,與化合物14水解、衍生化產(chǎn)物進(jìn)行比對。
化合物14為灰色無定形固體,易溶于氯仿, ESI質(zhì)譜顯示明顯的準(zhǔn)分子離子峰571 [M + Na]+, 表明分子量為548。通過HR-ESI-MS的準(zhǔn)分子離子峰549.2326 [M + H]+推出分子式為C28H36O11(計(jì)算值:549.2330)。1H NMR中,低場區(qū)有5個(gè)芳香質(zhì)子信號H6.85 (1H, d,= 8.0 Hz), 6.63 (1H, dd,= 8.0, 1.9 Hz), 6.59 (1H, d,= 1.9 Hz), 6.59 (1H, s)和6.28 (1H, s),通過耦合常數(shù)分析,可知H6.85、6.63、6.59為一組1,3,4三取代的苯環(huán)質(zhì)子信號,H6.59和H6.28為一組1,3,4,6四取代的苯環(huán)質(zhì)子信號;H4.66 (1H, d,= 1.7 Hz)和1.23 (3H, d,= 6.2 Hz)為鼠李糖的特征質(zhì)子信號。13C NMR譜中顯示了28個(gè)碳信號,結(jié)合HSQC,結(jié)構(gòu)中包括12個(gè)芳基碳,鼠李糖基6個(gè)碳,乙酰基2個(gè)碳(C171.7, 21.2), 2個(gè)甲氧基碳,3個(gè)亞甲基,3個(gè)次甲基。減去乙酰基、甲氧基、鼠李糖基,經(jīng)分析剩余的分子母核為木脂素。通過檢索文獻(xiàn),化合物14與文獻(xiàn)[12]報(bào)道的aviculin很相似,差異之處在于化合物14比aviculin多了1個(gè)乙?;MBC譜中,H2-9 (H4.35, 3.94)與乙?;械聂驶?C171.7)有明顯相關(guān)信號, 表明乙?;B接在C-9位(圖2: A)。H2-9的化學(xué)位移H4.35, 3.94比aviculin對應(yīng)的氫信號(H3.63, 3.71)向低場移動,進(jìn)一步證明乙?;B接在C-9位。1H-1H COSY譜圖中,觀察到H2-7與H-8、H-8與H2-9和H-8¢、H-8¢與H-7¢和H2-9¢有明顯相關(guān)信號,證明了如圖2: A中的H2-7/H-8/H2-9,H-8/H-8¢,和H-7¢/ H-8¢/H2-9¢自旋耦合體系。
圖1 化合物1~14的結(jié)構(gòu)
表1 化合物14的核磁共振氫譜(500 MHz)和碳譜數(shù)據(jù)(125 MHz)
對比-鼠李糖[13]和-鼠李糖[14]的碳譜數(shù)據(jù),化合物14中鼠李糖的碳譜數(shù)據(jù)與-鼠李糖的一致,表明化合物14中連接的鼠李糖為-構(gòu)型。化合物14經(jīng)酸水解、衍生化、HPLC分析,保留時(shí)間為22.4 min,l-鼠李糖標(biāo)品的保留時(shí)間為22.5 min, 表明化合物14中的鼠李糖為l構(gòu)型。
1H NMR中,H-7¢的偶合常數(shù)較大,為11.1 Hz,表明H-7¢和H-8¢處于直立鍵-直立鍵的相對位置。H2-7的2個(gè)質(zhì)子信號H2.86 (dd, 15.8, 5.0)和2.77 (dd, 15.8, 10.0),其中耦合常數(shù)15.8 Hz為H2-7中2個(gè)氫之間的2耦合,5.0和10.0 Hz為H2-7中2個(gè)氫分別與H-8的3耦合,5.0 Hz表明H-7和H-8處于平伏鍵-直立鍵的關(guān)系,10.0 Hz表明H-7和H-8處于直立鍵-直立鍵的相對位置(圖2: B)?;衔?4經(jīng)酸水解后所得苷元部分[]D20=-11.0 (0.1, MeOH), 對比化合物(-)-isolariciresinol的[]D25=-30.0 (12.0, MeOH)[15], 化合物(+)-isolariciresinol的[]D25=+68 (1.0, CHCl3)[16], 表明化合物14苷元部分的立體構(gòu)型與(-)-isolariciresinol一致。因此,化合物14的鑒定為(-)-9-acetyl-isolariciresinol9¢---l-rhamnopyra- noside (圖1)。
通過對比核磁共振波譜和質(zhì)譜數(shù)據(jù),13個(gè)已知化合物分別鑒定為5-hydroxy-3-methoxy-phenyl-6-- syringoyl--d-glucopyranoside (1)[17]、高良姜苷A (2)[18]、heterophylloside C[19]、6¢--vanilloy-lisotachio- side (4)[20]、3,4,5-trimethoxyphenyl-6--syringoyl--d- glucopyranoside (5)[21]、香草醛(6)[22]、丁香醛(7)[23]、3,4-二羥基苯甲醛(8)[24]、齊墩果酸(9)[25]、樺木酸(10)[26]、胡蘿卜苷(11)[27]、胡蘿卜苷亞油酸酯(12)[28]和(±)-lyoniresinol 2---rhamnoside (13)[29]。
圖2 化合物14的COSY和關(guān)鍵HMBC (A)及六元環(huán)的椅式構(gòu)象(B)
[1] Deletis Florae Reipublicae Popularis Sinicae, Agendae Academiae Sinicae Edita. Florae Reipublicae Popularis Sinicae, Tomus 20 [M]. Beijing: Science Press, 1982. [中國科學(xué)院中國植物志編輯委員會. 中國植物志, 第20卷 [M]. 北京: 科學(xué)出版社, 1982.]
[2] State Administration of Traditional Chinese Medicine. Chinese Materia Medica, Tomus 5 [M]. Shanghai: Shanghai Science and Technology Publishers, 1999: 365. [國家中醫(yī)藥管理局《中華本草》編委會. 中華本草, 第5卷 [M]. 上海: 上??茖W(xué)技術(shù)出版社, 1999: 365.]
[3] KE J L. Activity of extracts from Casuarinas Barks to scavenge hydroxyl free radicals [J]. Chem Ind For Prod, 2009, 29(4): 97–100. [柯金煉. 木麻黃樹皮提取物的清除羥自由基活性 [J]. 林產(chǎn)化學(xué)與工業(yè), 2009, 29(4): 97–100. doi: 10.3321/j.issn:0253-2417.2009.04.020.]
[4] LIU H L, ZHANG Y, ZHENG X L, et al. Research ofanti- bacterial activity ofand[J]. J Agric Univ Hebei, 2014, 37(5): 110–113. [劉海隆, 張艷, 鄭心力, 等. 木麻黃和地膽草體外抑菌試驗(yàn)研究 [J]. 河北農(nóng)業(yè)大學(xué)學(xué)報(bào), 2014, 37(5): 110–113. doi: 10.13320/j.cnki.jauh.2014.0123.]
[5] SHAFIQ Y, NAQVI B S, RIZWANI G H, et al. Anti-acne activity ofbark extract: A randomized clinical trial [J]. Bangladesh J Pharmacol, 2014, 9(3): 337–341. doi: 10.3329/bjp.v9i3. 19342.
[6] EL-TANTAWY W H, MOHAMED S A H, HALEEM E N A A. Evaluation of biochemical effects ofextract on gentamicin-induced nephrotoxicity and oxidative stress in rats: Phytochemical analysis [J]. J Clin Biochem Nutr, 2013, 53(3): 158–165. doi: 10.3164/jcbn.13-19.
[7] CHEN C M, CHEN I C, CHEN Y L, et al. Medicinal herbs(Blume) DC.,L. and(L.) Moench protect human cells from MPP+damage via inducingexpression [J]. Phytomedicine, 2016, 23(12): 1422–1433. doi: 10.1016/j.phymed.2016.08.004.
[8] AHER A N, PAL S C, PATIL U K, et al. Evaluation of anthistaminic activity offrost (Casuarinaceae) [J]. Pharmaco- logyonline, 2009, 1: 1144–1149.
[9] JIN Y, XU Y T, HUANG Z W, et al. Metabolite pattern in root nodules of the actinorhizal plant[J]. Phytochemistry, 2021, 186: 112724. doi: 10.1016/j.phytochem.2021.112724.
[10] XU X Y, CHEN L R, LUO Y C, et al. Discovery of cyclic diarylhe- ptanoids as inhibitors against influenza A virus from the roots of[J]. J Nat Prod, 2022, 85(9): 2142–2148. doi: 10.1021/acs.jnatprod.2c00335.
[11] GOU P, XIAO Y Y, LV L, et al. Hydroquinone and terpene glucosides fromand their lipase inhibitory activity [J]. Fitoterapia, 2018, 130: 89–93. doi: 10.1016/j.fitote.2018.08.010.
[12] KIM H J, WOO E R, PARK H. A novel lignan and flavonoids from[J]. J Nat Prod, 1994, 57(5): 581–586. doi: 10. 1021/np50107a003.
[13] KITE G C, STONEHAM C A, VEITCH N C. Flavonol tetraglycosides and other constituents from leaves of(Legu- minosae) and related taxa [J]. Phytochemistry, 2007, 68(10): 1407– 1416. doi: 10.1016/j.phytochem.2007.03.004.
[14] ABEYGUNAWARDANA C, BUSH C A, CISAR J O. Complete structure of the polysaccharide fromJ22 [J]. Biochemistry, 1990, 29(1): 234–248.
[15] CUTILLO F, D’ABROSCA B, DELLAGRECA M, et al. Lignans and neolignans from: Effects on seed germination and plant growth [J]. J Agric Food Chem, 2003, 51(21): 6165?6172. doi: 10.1021/jf034644c.
[16] FONSECA S F, DE PAIVA CAMPELLO J, BARATA L E S, et al.13C NMR spectral analysis of lignans from[J]. Phytochemistry, 1978, 17(3): 499–502. doi: 10.1016/S0031-9422(00) 89347-4.
[17] KHIEV P, CHIN Y W, CAI X F, et al. A new phenolic glycoside from[J]. J Korean Soc Appl Biol Chem, 2010, 53(2): 253–255. doi: 10.3839/jksabc.2010.040.
[18] AN N, LIN J, YANG S L, et al. A new glycoside from[J]. Acta Pharm Sin, 2006, 41(3): 233–235. [安寧, 林佳, 楊世林, 等. 高良姜根莖中的一個(gè)新糖苷 [J]. 藥學(xué)學(xué)報(bào), 2006, 41(3): 233–235. doi: 10.3321/j.issn:0513-4870.2006.03.009.]
[19] LI D X, YIN Y P, LI J, et al. Bibenzyl and phenolic glycosides from[J]. Phytochem Lett, 2015, 11: 220–223. doi: 10.1016/j.phytol.2015.01.003.
[20] YANG X W, WANG J S, MA Y L, et al. Bioactive phenols from the leaves of[J]. Planta Med, 2007, 73(13): 1415– 1417. doi: 10.1055/s-2007-990235.
[21] PAN H F, LUNDGREN L N. Rhododendrol glycosides and phenyl glucoside esters from inner bark of[J]. Phyto- chemistry, 1994, 36(1): 79–83. doi: 10.1016/S0031-9422(00)97017-1.
[22] ZHOU Y J, WANG J H, XUE Y F, et al. Study on chemical consti- tuents from active ethyl acetate fraction of[J]. Chin Trad Herb Drugs, 2021, 52(17): 5218–5225. [周宇娟, 王俊豪, 薛亞甫, 等. 鐵皮石斛醋酸乙酯部位化學(xué)成分研究 [J]. 中草藥, 2021, 52: 5218–5225. doi: 10.7501/j.issn.0253-2670.2021.17.013.]
[23] YU R, ZHANG Y, ZHENG D D, et al. Isolation and identification of phenolic components fromPursh [J]. Chin J Med Chem, 2021, 31(3): 203–208. [于芮, 張穎, 鄭丹丹, 等. 趕黃草中酚類成分的分離與鑒定 [J]. 中國藥物化學(xué)雜志, 2021, 31(3): 203–208. doi: 10.14142/j.cnki.cn21-1313/r.2021.03.005.]
[24] CHEN Y F, LIU S J, WANG F. Sesquiterpenoids of[J]. China J Chin Mat Med, 2012, 37(7): 946–950. [陳云飛, 劉守金, 王飛. 闊帶鳳丫蕨倍半萜類化學(xué)成分研究 [J]. 中國中藥雜志, 2012, 37(7): 946–950. doi: 10.4268/cjcmm20120717.]
[25] SEVINDIK H G, OZGEN U, ATILA A, et al. Phtytochemical studies and quantitative HPLC analysis of rosmarinic acid and luteolin 5--d-glucopyranoside onsubspvar[J]. Chem Pharm Bull, 2015, 63(9): 720–725. doi: 10.1248/ cpb.c14-00877.
[26] KHALIQ S, VOLK F J, FRAHM A W. Phytochemical investigation of[J]. Planta Med, 2007, 73(1): 77–83. doi: 10. 1055/s-2006-951766.
[27] FAIZI S, ALI M, SALEEM R, et al. Complete1H and13C NMR assignments of stigma-5-en-3---glucoside and its acetyl derivative [J]. Magn Reson Chem, 2001, 39(7): 399–405. doi: 10.1002/mrc.855.
[28] LONG Z M, WU L J, JIANG B Y, et al. Chemical constituents from the seeds ofBlume (Ⅲ) [J]. J Shenyang Pharm Univ, 2008, 25(11): 883–885. [龍志敏, 吳立軍, 江冰婭, 等. 板栗種仁的化學(xué)成分(Ⅲ) [J]. 沈陽藥科大學(xué)學(xué)報(bào), 2008, 25(11): 883–885.]
[29] KANEDA N, KINGHORN A D, FARNSWORTH N R, et al. Two diarylheptanoids and a lignan from[J]. Phytochemistry, 1990, 29(10): 3366–3368. doi: 10.1016/0031-9422(90) 80220-B.
Chemical Constituents of Ethyl Acetate Extract ofRoots
GAO Ruanling1,2, LUO Yucai2,3, MA Yongyi2,3, WANG Guokai1*, ZHOU Zhongyu1,2,3*
(1. School of Pharmacy, Anhui University of Chinese Medicine, Anhui Province Key Laboratory of Research & Development of Chinese Medicine, Hefei 230012, China; 2. Key Laboratory of South China Agricultural Plant Molecular Analysis and Genetic Improvement & Guangdong Provincial Key Laboratory of Applied Botany, South China Botanical Garden, Chinese Academy of Sciences, Guangzhou 510650, China; 3. South China National Botanical Garden, Guangzhou 510650, China)
To clarify the chemical constituents in, fourteen compounds were isolated by organic solvent extraction, fractionation, and a variety of chromatographic separation techniques. Based on spectroscopic data, their structures were identified as 5-hydroxy-3-methoxyphenyl-6--syringoyl--d-glucopy- ranoside (1), alpinoside A (2), heterophylloside C (3), 62--vanilloylisotachioside (4), 3,4,5-trimethoxyphenyl- 6--syringoyl--d-glucopyranoside (5), vanillin (6), syringaldehyde (7), 3,4-dihydroxybenzaldehyde (8), oleanolic acid (9), betulinic acid (10),-sitosterol glucoside (11), daucosterol-6¢-linoleate (12), (±)-lyoniresinol 2---rham- noside (13), and (-)-9-acetyl-isolariciresinol9¢---l-rhamnopyranoside (14). Among them, compound 14 is a new lignan derivative.
; Chemical component; Lignan
10.11926/jtsb.4747
2022-11-10
2022-12-30
國家自然科學(xué)基金項(xiàng)目(31970376);國家重點(diǎn)研發(fā)項(xiàng)目(2021YFC3100401)資助
This work was supported by the National Natural Science Foundation of China (Grant No. 31970376), the National Key Research and Development Program of China (Grant No. 2021YFC3100401).
高阮玲(1997年生),女,碩士研究生,研究方向天然藥物化學(xué)。E-mail: 2829420594@qq.com
通訊作者Corresponding author.E-mail: zhouzhongyu@scbg.ac.cn; wanggk@ahtcm.edu.cn